Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Prodia Diagnostic Line Tbk (PRDL) vs Sarimelati Kencana Tbk. (PZZA) Price & Performance

Prodia Diagnostic Line TbkTrade
Sarimelati Kencana Tbk.Trade

Price performance (Past 24H)

Key statistics

Prodia Diagnostic Line Tbk vs Sarimelati Kencana Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp268 (market cap 470.58B, 23.86M 24h volume), while Sarimelati Kencana Tbk. trades at Rp183 (market cap 549.98B, 255.8K 24h volume). The key difference: Sarimelati Kencana Tbk. is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (23.86M versus 255.8K). Which is the better fit depends on your goals.

PRDLPZZA
Market Cap
470.58B549.98B
Volume
23.86M255.8K
Lot
238.64K2.56K
Turnover
6.57B46.56M
Average Price
275.21182
Value
6.57B46.56M
Indicative Equilibrium Price
272
Indicative Equilibrium Volume
1.14K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PRDL
View details
PZZA
View details

About Prodia Diagnostic Line Tbk

PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.

Read more on PRDL

About Sarimelati Kencana Tbk.

PT Sarimelati Kencana Tbk. (the Company) was established based on Notarial Deed No. 132 dated December 16, 1987 of Lieke Lianadevi Tukgali, S.H.

Read more on PZZA